Cipla Limited (NSE: CIPLA) is an Indian multinational pharmaceutical and biopharmaceutical company. Founded in 1935, Cipla primarily develops and sells generic and over-the-counter drugs, active pharmaceutical ingredients, and biopharmaceuticals. The company has operations in over 80 countries, with a focus on the developing world. Cipla is known for its affordable and accessible medicines, particularly in the areas of HIV/AIDS, respiratory, and cardiovascular disease. Cipla has also invested in research and development to develop new drugs and expand its product portfolio.
The company’s revenue from operations for the quarter ended December 31st, 2022 was Rs. 5,730.08 crores from the sale of products and Rs. 80.01 crores from other operating revenue, for a total of Rs. 5,810.09 crores. For the nine months ended December 31st, 2022, the revenue from operations was Rs. 16,807.23 crores from the sale of products and Rs. 206.59 crores from other operating revenue, for a total of Rs. 17,013.82 crores. The company’s total income was Rs. 5,924.53 crores, which includes Rs. 114.44 crores from other income. For the nine months ended December 31st, 2022, the total income was Rs. 17,354.64 crores, which includes Rs. 340.82 crores from other income.
Cipla’s expenses for the quarter ended December 31st, 2022 were Rs. 4,706.47 crores, which includes Rs. 1,299.04 crores for cost of materials consumed, Rs. 948.69 crores for employee benefits expense, and Rs. 272.11 crores for depreciation, impairment, and amortisation expense. For the nine months ended December 31st, 2022, the expenses were Rs. 14,061.66 crores.
The company’s profit before exceptional items and tax for the quarter ended December 31st, 2022 was Rs. 1,218.06 crores, and for the nine months ended December 31st, 2022 was Rs. 3,292.98 crores. The net profit after tax before share of associates for the quarter ended December 31st, 2022 was Rs. 808.05 crores, and for the nine months ended December 31st, 2022 was Rs. 2,312.37 crores. The net profit for the period/year was Rs. 807.83 crores for the quarter ended December 31st, 2022, and Rs. 2,311.38 crores for the nine months ended December 31st, 2022.
Overall, it seems that Cipla has performed well in the quarter and nine months ended December 31st, 2022, with revenue and income growing, and expenses remaining relatively stable. The company’s profit before and after tax has also increased during this period.